Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,416 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment Results of High-dose-rate Brachytherapy and External Beam Radiation With Long-term Androgen Deprivation Therapy for Patients With Metastatic Prostate Cancer.
Suzuki H, Urabe F, Iwatani K, Miyajima K, Imai YU, Tashiro K, Tsuzuki S, Honda M, Koike Y, Aoki M, Sato S, Takahashi H, Miki K, Kimura T. Suzuki H, et al. Among authors: kimura t. Anticancer Res. 2023 Jul;43(7):3135-3143. doi: 10.21873/anticanres.16486. Anticancer Res. 2023. PMID: 37352008
Clinical characteristics of secondary bladder cancer developing after low-/high-dose-rate brachytherapy to treat localized prostate cancer.
Miyajima K, Suzuki H, Urabe F, Iwatani K, Imai Y, Yasue K, Yanagisawa T, Kimura S, Tashiro K, Tsuzuki S, Koike Y, Miki J, Yuen S, Sasaki T, Aoki M, Sato S, Takahashi H, Miki K, Kimura T. Miyajima K, et al. Among authors: kimura s, kimura t. Int J Clin Oncol. 2023 Sep;28(9):1200-1206. doi: 10.1007/s10147-023-02383-1. Epub 2023 Jul 11. Int J Clin Oncol. 2023. PMID: 37432614
Comparison of neoadjuvant and adjuvant chemotherapy for upper tract urothelial carcinoma in real-world practice: a multicenter retrospective study.
Takahashi K, Urabe F, Suhara Y, Nakano J, Yoshihara K, Goto Y, Sadakane I, Koike Y, Yata Y, Suzuki H, Kurawaki S, Miyajima K, Iwatani K, Imai Y, Sakanaka K, Nakazono M, Kurauchi T, Kayano S, Onuma H, Aikawa K, Yanagisawa T, Tashiro K, Tsuzuki S, Koike Y, Furuta A, Miki J, Kimura T. Takahashi K, et al. Among authors: kimura t. Jpn J Clin Oncol. 2023 Dec 7;53(12):1208-1214. doi: 10.1093/jjco/hyad118. Jpn J Clin Oncol. 2023. PMID: 37647644
Presurgical immune-oncology/tyrosine kinase inhibitor combination therapy for renal cell carcinoma with a vena cava tumor thrombus: a single-institution case series.
Urabe F, Iwatani K, Hashimoto M, Suzuki H, Miyajima K, Murakami M, Tashiro K, Tsuzuki S, Furuta A, Sato S, Takahashi H, Kimura T. Urabe F, et al. Among authors: kimura t. Transl Androl Urol. 2023 Aug 31;12(8):1321-1325. doi: 10.21037/tau-23-203. Epub 2023 Aug 10. Transl Androl Urol. 2023. PMID: 37680224 Free PMC article.
Clinical impact of detrusor muscle in en bloc resection for T1 bladder cancer.
Yanagisawa T, Sato S, Hayashida Y, Okada Y, Fukuokaya W, Iwatani K, Matsukawa A, Shimoda M, Takahashi H, Kimura T, Shariat SF, Miki J. Yanagisawa T, et al. Among authors: kimura t. Urol Oncol. 2023 Dec;41(12):484.e7-484.e15. doi: 10.1016/j.urolonc.2023.08.004. Epub 2023 Sep 14. Urol Oncol. 2023. PMID: 37714725
10,416 results
You have reached the last available page of results. Please see the User Guide for more information.